Key facts
- Notable investors include Oost NL, EIT RawMaterials, VP Capital (Goirle), Infinit Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for AFFIX Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for AFFIX Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AFFIX Labs
Operator of a chemical technology company intended to create new coating technologies and novel active formulations to help society fight communicable diseases. The company focuses on binding safe chemicals in a way that boosts their longevity and has led to products such as insect-repellent textile coating, focusing on fighting insect-borne diseases such as Malaria, Dengue, and Zika viruses, enabling companies with products to prevent the spread of communicable diseases via surface transmission or insect bite.
- Sector
- Materials and Resources
- HQ
- Helsinki, Finland
- Founded
- 2019
- Employees
- 2
- Website
- affixlabs.com/
- Ownership
- Privately Held (backing)
AFFIX Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AFFIX Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AFFIX Labs in its N-PORT filings yet. We sweep new filings monthly.